Evidence map›Paper›PMID 29606967›Full record

ArticleResearch in pharmaceutical sciences2018

Effects of oregano essential oil on brain TLR4 and TLR2 gene expression and depressive-like behavior in a rat model.

Azam Amiresmaeili, Samira Roohollahi, Ali Mostafavi, Nayere Askari

Open access · goldAbstract read
In one paragraph

Article in Research in pharmaceutical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Study of the Effects ofArchives of Razi Institute · 2022
    Article
  7. Article
  8. Article
  9. Molecules (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Research in pharmaceutical sciences · 2020
    Article
  14. Article
  15. Hydroalcoholic Extract ofIranian journal of pharmaceutical research : IJPR
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Azam AmiresmaeiliDepartment of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, I.R. Iran.
Samira RoohollahiDepartment of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, I.R. Iran.
Ali MostafaviDepartment of Chemistry, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, I.R. Iran.
Nayere AskariDepartment of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, I.R. Iran.
Shahid Bahonar University of Kerman · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to evaluate the effects of oregano essential oil (OEO) on the hippocampus and prefrontal cortex TLR 2/4 gene expression and depressive like behavior induced by chronic unpredictable stress (CUS). Sucrose preference and forced swim tests were adopted to examine the antidepressant effect. Control (CON), OEO, CUS, and CUS + OEO groups were used. The OEO and CUS + OEO groups received OEO (0.2 mL/kg, i.p.), CON and CUS received saline (0.2 mL/kg, i.p.), and the positive drug groups of CUS rats received fluoxetine (10 mg/kg) and diazepam (3 mg/kg) once daily for 14 days. The expression of TLR 2/4 was determined using real time quantitative polymerase chain reaction with the SYBR green reporter dye. The compositions of the OEO were determined by gas chromatography-mass spectroscopy. The main constituents were thymol (20.72%), gamma-terpinene (8.83%), borneol (8.72%), cymene (6.83%), carvacrol (6.274%), alfa-terpinene (5.26%), and sabinene (4.92%). Administration of OEO significantly alleviated the depressive symptoms of CUS. A higher level of TLR2/4 mRNA was seen in the brain of CUS group (

Indexed as

Chronic unpredictable stressDepressionOriganum vulgare L.Toll-like receptor 2Toll-like receptor 4

Identifiers

PMID29606967
PMCPMC5842484
OpenAlexW2788410238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.